About Us

Salipro® was born out of the need to improve. To make things work. To push things forward. 

All of us at Salipro Biotech have worked with challenging drug targets. Those membrane proteins are inherently unstable. We tried various methods to stabilize those membrane proteins. Some of them worked, some of them did not: but what all of those methods had in common - they were always laborious, time-consuming processes that required a lot of resources. We felt the need for something new. Something better. Something that would make a real difference. And we made Salipro®.

Ever since we started off from Karolinska Institutet in 2016, the Salipro® platform has enabled researchers in industry and academia worldwide to work with challenging drug targets. With drug targets where researchers had tried for months and years to make a drug target druggable. And that included ourselves. With the Salipro® platform, we are all in a position now where we can take a drug target from the cell, and make it amenable for drug development. For small molecules. For therapeutic peptides, antibodies and more. 

We feel together we can make a change. Together we can develop novel therapies. We make the undruggable druggable.